Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4793963
Max Phase: Preclinical
Molecular Formula: C31H22BrN3O4S
Molecular Weight: 612.51
Molecule Type: Unknown
Associated Items:
ID: ALA4793963
Max Phase: Preclinical
Molecular Formula: C31H22BrN3O4S
Molecular Weight: 612.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N#CC1=C(NCCC(=O)NCc2ccc(C(=O)O)cc2)c2ccc(Sc3ccc(Br)cc3)c3cccc(c23)C1=O
Standard InChI: InChI=1S/C31H22BrN3O4S/c32-20-8-10-21(11-9-20)40-26-13-12-23-28-22(26)2-1-3-24(28)30(37)25(16-33)29(23)34-15-14-27(36)35-17-18-4-6-19(7-5-18)31(38)39/h1-13,34H,14-15,17H2,(H,35,36)(H,38,39)
Standard InChI Key: BFOFAMCWDGSQFM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 612.51 | Molecular Weight (Monoisotopic): 611.0514 | AlogP: 6.18 | #Rotatable Bonds: 9 |
Polar Surface Area: 119.29 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.07 | CX Basic pKa: | CX LogP: 5.23 | CX LogD: 2.11 |
Aromatic Rings: 4 | Heavy Atoms: 40 | QED Weighted: 0.21 | Np Likeness Score: -1.00 |
1. Wang Z,Song T,Guo Z,Cao K,Chen C,Feng Y,Wang H,Yin F,Zhou S,Dai J,Zhang Z. (2020) Targeting the Allosteric Pathway That Interconnects the Core-Functional Scaffold and the Distal Phosphorylation Sites for Specific Dephosphorylation of Bcl-2., 63 (22): [PMID:33197310] [10.1021/acs.jmedchem.0c01290] |
Source(1):